Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats.
about
Orexin antagonists for neuropsychiatric disease: progress and potential pitfallsAn investigation of interactions between hypocretin/orexin signaling and glutamate receptor surface expression in the rat nucleus accumbens under basal conditions and after cocaine exposure.Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA?Orexin-A/Hypocretin-1 Mediates Cocaine-Seeking Behavior in the Posterior Paraventricular Nucleus of the Thalamus via Orexin/Hypocretin Receptor-2.Orexin/hypocretin receptor 1 signaling mediates Pavlovian cue-food conditioning and extinction.The Role of Orexins/Hypocretins in Alcohol Use and Abuse.Drug Seeking and Relapse: New Evidence of a Role for Orexin and Dynorphin Co-transmission in the Paraventricular Nucleus of the Thalamus
P2860
Q26852653-ACB62225-FB3C-46A9-AFF0-A2E5451696F9Q37406154-04793578-C10E-4D9A-A3A3-B8D509E374EEQ38221344-A611C2F6-AD05-473C-8035-C7776B4B49C1Q38829935-B303CCC2-45ED-4385-9631-1A65AC60619EQ42736700-CA56A84C-AF55-455D-964C-29C3616153F4Q47788221-865C3F21-467F-434B-89D6-A996D6B15ED2Q58698159-C92130F7-CE23-4E36-A473-959B4C4E452B
P2860
Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats.
@ast
Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats.
@en
type
label
Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats.
@ast
Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats.
@en
prefLabel
Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats.
@ast
Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats.
@en
P2093
P2860
P1433
P1476
Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats.
@en
P2093
Gary Aston-Jones
Phong H Do
Rachel J Smith
Ronald E See
P2860
P304
P356
10.1016/J.NEUROPHARM.2012.07.044
P577
2012-08-07T00:00:00Z